I. I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Bull Exp Biol Med. 2023 Apr;174(6):749-753. doi: 10.1007/s10517-023-05785-3. Epub 2023 May 10.
A recombinant form of pneumolysin from Streptococcus pneumoniae was obtained. By using Vector NTI Advance 11.0 bioinformatic analysis software, specific primers were designed in order to amplify the genome fragment of strain No. 3358 S. pneumoniae serotype 19F containing the nucleotide sequence encoding the full-length pneumolysin protein. A PCR product with a molecular weight corresponding to the nucleotide sequence of the S. pneumoniae genome fragment encoding the full-length pneumolysin was obtained. An expression system for recombinant pneumolysin in E. coli was constructed. Sequencing confirmed the identity of the inserted nucleotide sequence encoding the full-length recombinant pneumolysin synthesized in E. coli M15 strain. Purification of the recombinant protein was performed by affinity chromatography using Ni-Sepharose in 8 M urea buffer solution. Confirmation of the recombinant protein was performed by immunoblotting with monoclonal antibodies to pneumolysin.
获得了肺炎链球菌肺炎球菌溶素的重组形式。使用 Vector NTI Advance 11.0 生物信息学分析软件,设计了特异性引物,以扩增含有全长肺炎球菌溶素蛋白编码核苷酸序列的 19F 血清型 3358 肺炎链球菌基因组片段。获得了与编码全长肺炎球菌溶素的肺炎链球菌基因组片段的核苷酸序列相对应的分子量为 PCR 产物。构建了用于在大肠杆菌中表达重组肺炎球菌溶素的表达系统。测序证实了插入的核苷酸序列编码在大肠杆菌 M15 菌株中合成的全长重组肺炎球菌溶素的身份。通过在 8 M 尿素缓冲液中使用 Ni-Sepharose 亲和层析纯化重组蛋白。用抗肺炎球菌溶素的单克隆抗体进行免疫印迹确认重组蛋白。